Lpl Financial LLC Vyne Therapeutics Inc. Transaction History

Lpl Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.12 - $4.91 $48 - $1,964	-400 Reduced 2.31%	16,912 $2,000
Q2 2022 Aug 12, 2022	SELL	$0.37 - $0.71 $277 - $532	-750 Reduced 4.15%	17,312 $7,000
Q4 2021 Feb 14, 2022	SELL	$0.91 - $1.5 $11 - $19	-13 Reduced 0.07%	18,062 $18,000
Q3 2021 Nov 15, 2021	BUY	$1.39 - $3.47 $3,822 - $9,542	2,750 Added 17.94%	18,075 $25,000
Q2 2021 Aug 13, 2021	BUY	$3.24 - $6.92 $2,430 - $5,190	750 Added 5.15%	15,325 $54,000
Q1 2021 May 14, 2021	BUY	$6.34 - $12.68 $92,405 - $184,811	14,575 New	14,575 $100,000

36.5K

Ticker VYNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,005,600
Market Cap $184M
Description
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.